Caballero, Teresa http://orcid.org/0000-0003-3005-9858
Alonso, Carmen
Baeza, María Luisa
Baynova, Krasimira
Cabeza, José
Cortés, Isabel
Escobar Oblitas, Danilo
Guilarte, Mar
Joral, Alejandro
Jurado Palomo, Jesús
Lara Jiménez, María Ángeles
Martínez Virto, Ana
Medrano, Laura
Monte Boquet, Emilio
Navarro, Montserrat
Pérez, Diego
Plá Martí, María José
Smith Foltz, Sara L.
Suero, Coral
Zamora, Carolina
Funding for this research was provided by:
CSL Behring (CSL Behring (ESP))
Article History
Received: 9 July 2023
Accepted: 1 April 2024
First Online: 21 May 2024
Declarations
:
: Not applicable.
: TC has the following conflict of interests: receipt of grants/research supports or participation in educational activities, research projects, scientific meetings (either attendance, speaking and/or delivering presentations) and advisory boards sponsored by AEDAF, Astria, BioCryst, CSL Behring, IONIS, Kalvista, Novartis, Octapharma, Pharming, Pharvaris and Takeda; and is a researcher from the IdiPAZ program for promoting research activities. MLB has the following conflict of interests: receipt of grants/research supports or participation in educational activities, research projects, scientific meetings (either attendance, speaking and/or delivering presentations) and advisory boards sponsored by CSL Behring, Novartis, Leti, Takeda, BioCryst and Pharming NV. KB has the following conflict of interests: receipt of grants/research supports or participation in educational activities, research projects, scientific meetings (either attendance, speaking and/or delivering presentations) and advisory boards sponsored by CSL Behring, Takeda, Pharming and BioCryst. MG has the following conflict of interests: receipt of grants/research supports or participation in educational activities, research projects, scientific meetings (either attendance, speaking and/or delivering presentations) and advisory boards sponsored by BioCryst, CSL Behring, Novartis, Pharming, Pharvaris and Takeda; and is a researcher from the VHIR program for promoting research activities. JJP has the following conflict of interests: participation in educational activities, research projects, scientific meetings (either attendance, speaking and/or delivering presentations) and advisory boards sponsored by CSL Behring. MALJ has the following conflict of interests: receipt of grants/research supports or participation in educational activities, research projects, scientific meetings (either attendance, speaking and/or delivering presentations) and advisory boards sponsored by GSK, Novartis, Behring, Takeda, Leti, Diater, Sanofi, ALK, Stallergenes, Bial, Allergy Therapeutics. AMV has the following conflict of interest: receipt of grants/research supports or participation in educational activities, research projects, scientific meetings (either attendance, speaking and/or delivering presentations) and advisory boards sponsored by CSL Behring and Takeda. LM has the following conflict of interests: participation in research projects from Tab Healthcare Research. EMB has the following conflict of interests: receipt of grants/research supports or participation in educational activities, research projects, scientific meetings (either attendance, speaking and/or delivering presentations) and advisory boards sponsored by Abbott/Abbvie, Amgen, Astellas, Astra Zeneca, Baxalta, Bayer, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Chiesi, CSL Behring, Eisai, Fresenius, Gilead, GSK, Ipsen, Janssen, Leo Pharma, Lilly, MSD, Merck-Serono, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Theramex, UCB and ViiV. DP has the following conflict of interests: participation in research projects by CSL Behring. MJPM has the following conflict of interests: participation in educational activities, research projects, scientific meetings (either attendance, speaking and/or delivering presentations) and advisory boards sponsored by CSL Behring, GSK, AstraZeneca, Takeda, Allergy Therapeutics, Roxall, LETI. IC is employed by CSL Behring. CA, JC, ADE, AJ, SLSF, MN, CS and CZ declare that they have no competing interests.